Healthcare provider profile · identity verified

Stanley W Dowell, MD

Internal Medicine · MEMPHIS, TN · NPI 1588618599

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	858	267
Atorvastatin Calcium	Atorvastatin Calcium	734	233
Losartan Potassium	Losartan Potassium	304	93
Potassium Chloride	Potassium Chloride	295	85
Omeprazole	Omeprazole	275	94
Pantoprazole Sodium	Pantoprazole Sodium	273	82
Glimepiride	Glimepiride	269	75
Gabapentin	Gabapentin	260	61
Simvastatin	Simvastatin	259	83
Furosemide	Furosemide	247	72
Carvedilol	Carvedilol	214	75
Tamsulosin Hcl	Tamsulosin Hcl	198	60
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	188	52
Allopurinol	Allopurinol	180	54
Metformin Hcl Er	Metformin Hcl	180	56
Diclofenac Sodium	Diclofenac Sodium	178	64
Hydrochlorothiazide	Hydrochlorothiazide	167	53
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	164	45
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	152	30
Metformin Hcl	Metformin Hcl	144	43
Albuterol Sulfate Hfa	Albuterol Sulfate	137	47
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	136	37
Hydralazine Hcl	Hydralazine Hcl	133	42
Labetalol Hcl	Labetalol Hcl	132	38
Levothyroxine Sodium	Levothyroxine Sodium	132	42
Atenolol	Atenolol	124	36
Lisinopril	Lisinopril	121	46
Lorazepam	Lorazepam	115	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	111	18
Metoprolol Tartrate	Metoprolol Tartrate	108	42
Pravastatin Sodium	Pravastatin Sodium	107	32
Clopidogrel	Clopidogrel Bisulfate	106	33
Eliquis	Apixaban	104	27
Metoprolol Succinate	Metoprolol Succinate	104	33
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	103	33
Zolpidem Tartrate	Zolpidem Tartrate	98	22
Felodipine Er	Felodipine	94	27
Spironolactone	Spironolactone	94	30
Valsartan	Valsartan	93	27
Trulicity	Dulaglutide	91	13
Ozempic	Semaglutide	90	21
Jardiance	Empagliflozin	89	17
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	88	29
Meloxicam	Meloxicam	88	32
Rosuvastatin Calcium	Rosuvastatin Calcium	82	34
Alprazolam	Alprazolam	78	suppressed
Fluticasone Propionate	Fluticasone Propionate	74	35
Trazodone Hcl	Trazodone Hcl	68	19
Ibuprofen	Ibuprofen	64	25
Montelukast Sodium	Montelukast Sodium	61	26
Donepezil Hcl	Donepezil Hcl	56	18
Hydrocortisone	Hydrocortisone	53	18
Naproxen	Naproxen	52	24
Esomeprazole Magnesium	Esomeprazole Magnesium	51	13
Alendronate Sodium	Alendronate Sodium	49	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	47	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	45	14
Escitalopram Oxalate	Escitalopram Oxalate	44	suppressed
Famotidine	Famotidine	44	14
Olmesartan Medoxomil	Olmesartan Medoxomil	41	12
Celecoxib	Celecoxib	39	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	17
Benazepril Hcl	Benazepril Hcl	38	15
Pioglitazone Hcl	Pioglitazone Hcl	38	11
Temazepam	Temazepam	38	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	37	suppressed
Januvia	Sitagliptin Phosphate	37	13
Warfarin Sodium	Warfarin Sodium	37	suppressed
Farxiga	Dapagliflozin Propanediol	36	12
Verapamil Er	Verapamil Hcl	36	suppressed
Chlorthalidone	Chlorthalidone	35	11
Nebivolol Hcl	Nebivolol Hcl	34	11
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Oxycodone Hcl	Oxycodone Hcl	33	suppressed
Desoximetasone	Desoximetasone	32	15
Glipizide	Glipizide	31	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	30	suppressed
Lansoprazole	Lansoprazole	30	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	30	suppressed
Nifedipine Er	Nifedipine	30	14
Meclizine Hcl	Meclizine Hcl	29	15
Isosorbide Dinitrate	Isosorbide Dinitrate	28	suppressed
Digoxin	Digoxin	27	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	27	suppressed
Methylprednisolone	Methylprednisolone	27	23
Ramipril	Ramipril	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	16
Dropsafe Prep Pads	Alcohol Antiseptic Pads	26	suppressed
Glipizide Er	Glipizide	26	suppressed
Brilinta	Ticagrelor	25	suppressed
Finasteride	Finasteride	25	suppressed
Levetiracetam	Levetiracetam	25	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	20
Nystatin	Nystatin	21	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Indapamide	Indapamide	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Nabumetone	Nabumetone	19	suppressed
Prednisone	Prednisone	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Sertraline Hcl	Sertraline Hcl	18	suppressed
Azithromycin	Azithromycin	17	17
Baclofen	Baclofen	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Glyburide	Glyburide	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Colchicine	Colchicine	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Fluconazole	Fluconazole	16	11
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Premarin	Estrogens, Conjugated	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Torsemide	Torsemide	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	13
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Risperidone	Risperidone	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Cephalexin	Cephalexin	13	12
Clorazepate Dipotassium	Clorazepate Dipotassium	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Etodolac	Etodolac	13	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Unifine Pentips Plus	Pen Needle, Diabetic	13	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Prevacid	Lansoprazole	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Mounjaro	Tirzepatide	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error